Skip to main navigation Skip to search Skip to main content

Mimic catechins to develop selective MMP-2 inhibitors

  • Antonella Di Pizio
  • , Mariangela Agamennone
  • , Antonio Laghezza
  • , Fulvio Loiodice
  • , Paolo Tortorella
  • The Hebrew University of Jerusalem
  • University G. d’Annunzio of Chieti-Pescara
  • University of Bari

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Abstract: Matrix metalloproteinase 2 (MMP-2) is a well-known anticancer target belonging to the MMP family. Because of the bilateral role of MMPs in cancer, developing highly selective MMP-2 inhibitors is a current challenge. In this paper, we investigated the binding modes of green tea polyphenols epigallocatechin gallate and epicatechin into the active site of the MMP-2 enzyme. The structure-based analysis allowed the optimization of these hits and hence led to a better lead candidate. Moreover, using a pharmacophore model, we screened FooDB compounds and selected food components as potential MMP-2 inhibitors. The search for food-derived compounds that target this enzyme may represent a strategy to identify new lead molecules with improved safety profiles and provide indications about possible functional foods. Graphical abstract: [Figure not available: see fulltext.].

Original languageEnglish
Pages (from-to)1293-1300
Number of pages8
JournalMonatshefte für Chemie
Volume149
Issue number7
DOIs
StatePublished - 1 Jul 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Anticancer drugs
  • Enzymes
  • Flavonoids
  • Ligands
  • MMP inhibitors
  • Molecular modelling

Fingerprint

Dive into the research topics of 'Mimic catechins to develop selective MMP-2 inhibitors'. Together they form a unique fingerprint.

Cite this